Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

BATS BZX Real-Time Price
As of 12:52pm ET
 -0.92 / -1.51%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Generic

Company Description

Teva Pharmaceutical Industries Ltd. is engaged in the provision of pharmaceutical services. It operates through the following business divisions: Generic, Branded, and Over-the-Counter (OTC). The Generic division involves the manufacture and sale of generic products such as tablets, capsules, ointments, creams, liquids, injectables, and inhalants. The Branded division provides products for central nervous system (CNS), respiratory system, women's health, oncology, and others. The OTC division offers medicines in categories such as cough and cold, allergy, digestive wellness, vitamins, minerals and supplements, analgesics, and skin medications. Its products are manufactured under the Copaxone, Provigil, Azilect, Nuvigil, ProAir, Qvar, Treanda, Lonquex, Revascor, Milprosa, LeCette, Quartette, NexoBrid, and StemEx brand names. The company was founded in 1901 and is headquartered in Petach Tikva, Israel.

Contact Information

Teva Pharmaceutical Industries Ltd.
5 Basel Street
Petach Tikva -- 49131
P:(723) 926-7267
Investor Relations:
(215) 591-8912



Mutual fund holders28.13%
Other institutional27.02%
Individual stakeholders--

Top Executives

Erez VigodmanPresident, Chief Executive Officer & Director
Carlo de NotaristefaniPresident & CEO-Global Operations
Eyal DeshehChief Financial Officer
Michael R. HaydenPresident-Global Research & Development
Yafit StarkChief Clinical Officer

To view my watchlist

Not a member yet?

Sign up now for a free account